查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2029984

全球海洋低聚醣市場：按產品類型、原料、應用和地區分類－市場規模、產業動態、機會分析和預測（2026-2035 年）

Global Marine Oligosaccharides Market: By Product Type, Source, Application, Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035
出版日期: | 出版商: Astute Analytica | 英文 260 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球海洋來源低聚醣市場持續穩定成長，反映出其在多個高附加價值產業中日益成長的重要性。 2025年，該市場規模為38.256億美元，預計到2035年將達到約63.8441億美元。此成長軌跡意味著2026年至2035年預測期間的複合年成長率（CAGR）為5.32%，顯示市場呈現持續上升趨勢，而非短期波動。

推動這一成長的主要因素是全球對天然來源和永續來源成分日益成長的需求。消費者和製造商都越來越傾向於選擇兼具功能性和環境效益的生物基替代品，從而逐漸減少對合成添加劑的使用。源自海藻和甲殼類動物等海洋來源的寡醣，因其可再生、可生物分解且適用於潔淨標示產品配方，滿足了這項需求。

顯著的市場趨勢

海洋來源的寡醣市場呈現寡占結構，少數幾家老字型大小企業對生產、定價和技術方向有顯著的影響力。這種集中度源自於極高的進入門檻，包括巨額資本投入、複雜的加工基礎設施以及對先進技術專長的需求。

前五的公司總合佔了約55%的市場總收入，顯示市場整合程度中等至較高。雖然小規模的公司在細分領域仍有發展空間，但整體市場結構更有利於擁有整合供應鏈、強大研發能力和全球分銷網路的老字型大小企業。

在主要企業中，青島博澤寡糖生物科技有限公司憑藉其在海藻加工方面的專業技術，在藻酸鹽寡糖領域佔據了穩固的地位。總部位於冰島的Primex ehf公司憑藉其專有的「ChitoClear」技術和強調永續性和資源完全利用的零廢棄物生物精煉模式，在北大西洋殼寡糖市場佔據了顯著的主導地位。同時，金殼製藥憑藉其垂直整合的業務結構以及在原料採購和下游加工方面的強大實力，在甲殼類動物源寡糖的價值鏈中佔據主導地位。

主要成長要素

海洋來源寡糖市場的主要驅動力是消費者和臨床界對具有顯著療效的成分日益成長的需求。隨著現代醫療保健的重點轉向預防和有針對性的營養干預，功能性成分的具體生理益處正受到更嚴格的審查。這提升了經科學檢驗的化合物的重要性，而海洋來源寡糖因其已證實的生物活性以及對人類健康關鍵方面（尤其是腸道微生物群）的潛在影響，而成為一種極具吸引力的選擇。

新機會的趨勢

先進的萃取技術正在海洋寡糖市場中發揮變革性作用，重塑生產效率和盈利。隨著競爭加劇和對高純度、功能穩定產品的需求不斷成長，製造商正轉向更先進的加工方法，以最佳化產量和成本結構。這些創新不僅提高了提取製程的技術性能，而且透過減少廢棄物、降低單位生產成本和提高產品質量，直接影響企業的經營性息稅折舊攤提前利潤 (EBITDA)。

最佳化障礙

建造先進的海洋寡糖提取和解聚設施需要大量的初期投資，使其成為整個生物基加工產業中資本密集度最高的領域之一。將海洋生質能轉化為高純度寡糖所需的基礎設施包括先進技術，例如可控酶水解系統、薄膜過濾系統和精密乾燥設備。除了核心加工設施外，企業還必須投資建造品管實驗室、廢棄物管理系統，並確保符合嚴格的環境和食品/藥品安全法規，所有這些都會顯著增加初始成本。

目錄

第1章執行摘要：全球海洋低聚醣市場

第2章：調查方法與研究框架

  • 研究目標
  • 產品概述
  • 市場區隔
  • 定性研究
    • 一手和二手資訊
  • 量化研究
    • 一手和二手資訊
  • 主要調查受訪者組成：按地區分類
  • 本研究的前提
  • 市場規模估算
  • 數據三角測量

第3章：全球海洋低聚醣市場概覽

  • 產業價值鏈分析
  • 產業展望
    • 對功能性和營養補充劑成分的需求不斷成長
    • 海洋生物技術的發展
    • 在化妝品和抗衰老產品中的使用量增加
    • 在製藥領域不斷拓展的應用
    • 海洋資源的永續利用
    • 潔淨標示和天然成分的發展趨勢
  • PESTLE分析
  • 波特五力分析
  • 市場動態和趨勢
    • 成長要素
      • 對海洋來源生物活性化合物日益成長的需求正在推動市場成長。
    • 抑制因子
    • 機會
    • 主要趨勢
  • 市場成長及前景
    • 2020-2035年市場收入估算與預測
    • 定價和成本結構分析

第4章：競爭對手儀錶板

  • 市場集中度
  • 企業市場占有率分析，2025 年
  • 競爭對手分析與基準測試
  • Start-Ups生態系分析
  • 併購和資金籌措趨勢

第5章：海洋來源寡糖的全球市場分析

  • 關鍵見解
  • 市場規模及預測，2020-2035年
    • 依產品類型
      • 半乳寡糖
      • 殼寡糖
      • 岩藻寡糖
      • 甘露寡糖
    • 來源
      • 貝類和甲殼類動物
      • 海藻
      • 魚
    • 透過使用
      • 食品/飲料
      • 製藥
      • 個人護理化妝品
      • 動物飼料
    • 按地區
      • 北美洲
        • 美國
        • 加拿大
        • 墨西哥
      • 歐洲
        • 西歐
          • 英國
          • 德國
          • 法國
          • 義大利
          • 西班牙
          • 其他西歐國家
        • 東歐
          • 波蘭
          • 俄羅斯
          • 其他東歐國家
      • 亞太地區
        • 中國
        • 印度
        • 日本
        • 韓國
        • 澳洲和紐西蘭
        • ASEAN
          • 印尼
          • 馬來西亞
          • 泰國
          • 新加坡
          • 其他東南亞國協
        • 其他亞太國家
      • 中東和非洲
        • UAE
        • 沙烏地阿拉伯
        • 南非
        • 其他中東和非洲國家
      • 南美洲
        • 阿根廷
        • 巴西
        • 其他南美國家

第6章：北美海洋來源寡糖市場分析

第7章：歐洲海洋寡醣市場分析

第8章：亞太海洋低聚醣市場分析

第9章：中東和非洲海洋來源寡醣市場分析

第10章：南美洲海洋來源寡糖市場分析

第11章：公司簡介

  • FMC Corporation
  • Alfa Chemistry
  • Gobalsir Inc
  • Cargill
  • DSM
  • DuPont de Nemours, Inc.
  • CP Kelco
  • KIMICA Corporation
  • Gelymar SA
  • Qingdao BZ Oligo Biotech Co., Ltd.
  • Golden-Shell Pharmaceutical Co., Ltd.
  • Seagarden AS
  • Algaia SA
  • BioAtlantis Ltd.
  • Other Prominent Players

第12章附錄

簡介目錄
Product Code: AA04261767

The global marine oligosaccharides market is undergoing steady and sustained expansion, reflecting its increasing relevance across multiple high-value industries. In 2025, the market was valued at USD 3,802.56 million, and it is projected to reach approximately USD 6,384.41 million by 2035. This growth trajectory corresponds to a compound annual growth rate (CAGR) of 5.32% over the forecast period from 2026 to 2035, indicating a stable rise rather than short-term volatility.

A key factor driving this growth is the rising global demand for natural and sustainably sourced ingredients. Consumers and manufacturers alike are increasingly shifting away from synthetic additives in favor of bio-based alternatives that offer both functional and environmental benefits. Marine oligosaccharides, derived from sources such as seaweed and crustaceans, align well with this demand due to their renewable origin, biodegradability, and compatibility with clean-label product formulations.

Noteworthy Market Developments

The marine oligosaccharides market operates within an oligopolistic structure, where a relatively small number of well-established companies hold significant influence over production, pricing, and technological direction. This concentration is largely the result of formidable barriers to entry, including substantial capital requirements, complex processing infrastructure, and the need for advanced technical expertise.

The top five players collectively account for approximately 55% of total market revenue, indicating a moderate to high level of consolidation. While there is still room for smaller firms to operate in niche segments, the overall market structure favors established companies with integrated supply chains, strong R&D capabilities, and global distribution networks.

Among the leading participants, Qingdao BZ Oligo Biotech has established a strong position in the alginate oligosaccharide segment, leveraging its expertise in seaweed-based processing. Primex ehf, based in Iceland, exerts significant control over North Atlantic chitooligosaccharides through its proprietary "ChitoClear" technology and a zero-waste biorefinery model that emphasizes sustainability and full resource utilization. Meanwhile, Golden-Shell Pharmaceutical dominates the crustacean-derived oligosaccharide value chain, supported by its vertically integrated operations and strong presence in raw material sourcing and downstream processing.

Core Growth Drivers

The core force propelling the marine oligosaccharides market is the rapidly increasing demand from both consumers and the clinical community for ingredients that deliver high, measurable efficacy. As the focus of modern healthcare shifts toward prevention and targeted nutritional interventions, there is growing scrutiny over whether functional ingredients can produce tangible physiological benefits. This has elevated the importance of scientifically validated compounds, positioning marine oligosaccharides as a compelling option due to their demonstrated bioactivity and potential to influence key aspects of human health, particularly within the gut microbiome.

Emerging Opportunity Trends

Advanced extraction technologies are playing a transformative role in reshaping production efficiency and profitability within the marine oligosaccharides market. As competition intensifies and demand for high-purity, functionally consistent products increases, manufacturers are turning to more sophisticated processing methods to optimize both yield and cost structures. These innovations are not only improving the technical performance of extraction processes but are also directly influencing operational EBITDA by reducing waste, lowering input costs per unit of output, and enhancing product quality.

Barriers to Optimization

Establishing a modern marine oligosaccharide extraction and depolymerization facility requires a substantial upfront financial commitment, making it one of the more capital-intensive segments within the broader bio-based processing industry. The infrastructure needed to convert marine biomass into high-purity oligosaccharides involves advanced technologies such as controlled enzymatic hydrolysis systems, membrane filtration units, and precision drying equipment. In addition to the core processing setup, companies must also invest in quality control laboratories, waste management systems, and compliance with stringent environmental and food or pharmaceutical safety regulations, all of which significantly add to the initial cost burden.

Detailed Market Segmentation

By source, the seaweed segment accounted for the largest share of the marine oligosaccharides market in 2025, contributing 45.25% of total revenue. This strong position reflects the strategic advantages offered by marine macroalgae as a raw material, particularly in terms of availability, compositional diversity, and sustainability. As industries increasingly prioritize renewable and scalable biological resources, seaweed has emerged as a highly attractive feedstock for the production of value-added oligosaccharides.

By product type, the chitooligosaccharides (COS) segment led the marine oligosaccharides market in 2025, accounting for the largest share due to its distinct functional and commercial advantages. This leadership position is closely tied to the material's unique origin and versatility across multiple end-use industries, including food, pharmaceuticals, and cosmetics. As demand for bioactive marine-derived ingredients continues to grow, COS has emerged as a preferred choice because of its well-documented properties and adaptability in formulation.

By application, the food and beverages segment accounted for the largest share of the marine oligosaccharides market in 2025, contributing 38.78% of total revenue. This leading position reflects a broader shift in how these compounds are being utilized across industries. What was once a specialized ingredient largely confined to premium dietary supplements has steadily moved into the mainstream food ecosystem, where it is now incorporated into a wide variety of everyday products. This transition highlights both the scalability of marine oligosaccharides and their growing acceptance among mass-market consumers.

Segment Breakdown

By Source

  • Seaweed
  • Shellfish
  • Fish

By Product Type

  • Fucooligosaccharides
  • Chitooligosaccharides
  • Mannooligosaccharides
  • Galactooligosaccharides

By Application

  • Food and Beverages
  • Pharmaceuticals
  • Personal Care and Cosmetics
  • Animal Feed

By Region

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa (MEA)
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Rest of South America

Geography Breakdown

  • Europe held the leading share of the marine oligosaccharides market in 2025, reflecting a position built through long-term structural advantages rather than short-term fluctuations. This dominance stems from sustained and deliberate investment in what is often referred to as the "Blue Bioeconomy," where marine resources are developed into high-value products for health, nutrition, and industrial use.
  • A key factor underpinning this leadership is the region's high level of consumer awareness, particularly in relation to preventative healthcare and gut health. European consumers have shown a strong inclination toward functional ingredients that support digestive wellness, immunity, and overall health, which has driven consistent demand for marine oligosaccharides.
  • In addition to demand-side dynamics, Europe benefits from a deeply integrated manufacturing base that spans the cosmetics, nutraceutical, and pharmaceutical industries. This interconnected industrial network allows for efficient translation of raw marine inputs into a diverse range of finished goods, from dietary supplements to advanced skincare formulations.

Leading Market Participants

  • FMC Corporation
  • Alfa Chemistry
  • Gobalsir Inc
  • Cargill
  • DSM
  • Other Prominent Players

Table of Content

Chapter 1. Executive Summary: Global Marine Oligosaccharides Market

Chapter 2. Research Methodology & Research Framework

  • 2.1. Research Objective
  • 2.2. Product Overview
  • 2.3. Market Segmentation
  • 2.4. Qualitative Research
    • 2.4.1. Primary & Secondary Sources
  • 2.5. Quantitative Research
    • 2.5.1. Primary & Secondary Sources
  • 2.6. Breakdown of Primary Research Respondents, By Region
  • 2.7. Assumption for Study
  • 2.8. Market Size Estimation
  • 2.9. Data Triangulation

Chapter 3. Global Marine Oligosaccharides Market Overview

  • 3.1. Industry Value Chain Analysis
    • 3.1.1. Raw Material Suppliers (Seaweed, Crustaceans, Marine Biomass)
    • 3.1.2. Extraction & Processing Companies
    • 3.1.3. Ingredient Manufacturers
    • 3.1.4. Distributors & Suppliers
    • 3.1.5. End Users (Food, Pharma, Cosmetics, Agriculture)
    • 3.1.6. Regulatory Bodies
  • 3.2. Industry Outlook
    • 3.2.1. Rising Demand for Functional & Nutraceutical Ingredients
    • 3.2.2. Growth in Marine Biotechnology
    • 3.2.3. Increasing Use in Cosmetics & Anti-aging Products
    • 3.2.4. Expansion of Pharmaceutical Applications
    • 3.2.5. Sustainable Marine Resource Utilization
    • 3.2.6. Clean-label & Natural Ingredient Trends
  • 3.3. PESTLE Analysis
  • 3.4. Porter's Five Forces Analysis
    • 3.4.1. Bargaining Power of Suppliers
    • 3.4.2. Bargaining Power of Buyers
    • 3.4.3. Threat of Substitutes
    • 3.4.4. Threat of New Entrants
    • 3.4.5. Degree of Competition
  • 3.5. Market Dynamics and Trends
    • 3.5.1. Growth Drivers
      • 3.5.1.1. Increasing demand for marine-derived bioactive compounds in boosting the market growth.
    • 3.5.2. Restraints
    • 3.5.3. Opportunity
    • 3.5.4. Key Trend
  • 3.6. Market Growth and Outlook
    • 3.6.1. Market Revenue Estimates and Forecast (US$ Mn), 2020 - 2035
    • 3.6.2. Pricing & Cost Structure Analysis

Chapter 4. Competition Dashboard

  • 4.1. Market Concentration Rate
  • 4.2. Company Market Share Analysis (Value %), 2025
  • 4.3. Competitor Mapping & Benchmarking
  • 4.4. Startup Ecosystem Analysis
  • 4.5. M&A and Funding Landscape

Chapter 5. Global Marine Oligosaccharides Market Analysis

  • 5.1. Key Insights
  • 5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 5.2.1. By Product Type
      • 5.2.1.1. Galactooligosaccharides
      • 5.2.1.2. Chitooligosaccharides
      • 5.2.1.3. Fucooligosaccharides
      • 5.2.1.4. Mannooligosaccharides
    • 5.2.2. By Source
      • 5.2.2.1. Shellfish
      • 5.2.2.2. Seaweed
      • 5.2.2.3. Fish
    • 5.2.3. By Application
      • 5.2.3.1. Food And Beverages
      • 5.2.3.2. Pharmaceuticals
      • 5.2.3.3. Personal Care And Cosmetics
      • 5.2.3.4. Animal Feed
    • 5.2.4. By Region
      • 5.2.4.1. North America
        • 5.2.4.1.1. The U.S.
        • 5.2.4.1.2. Canada
        • 5.2.4.1.3. Mexico
      • 5.2.4.2. Europe
        • 5.2.4.2.1. Western Europe
          • 5.2.4.2.1.1. The UK
          • 5.2.4.2.1.2. Germany
          • 5.2.4.2.1.3. France
          • 5.2.4.2.1.4. Italy
          • 5.2.4.2.1.5. Spain
          • 5.2.4.2.1.6. Rest of Western Europe
        • 5.2.4.2.2. Eastern Europe
          • 5.2.4.2.2.1. Poland
          • 5.2.4.2.2.2. Russia
          • 5.2.4.2.2.3. Rest of Eastern Europe
      • 5.2.4.3. Asia Pacific
        • 5.2.4.3.1. China
        • 5.2.4.3.2. India
        • 5.2.4.3.3. Japan
        • 5.2.4.3.4. South Korea
        • 5.2.4.3.5. Australia & New Zealand
        • 5.2.4.3.6. ASEAN
          • 5.2.4.3.6.1. Indonesia
          • 5.2.4.3.6.2. Malaysia
          • 5.2.4.3.6.3. Thailand
          • 5.2.4.3.6.4. Singapore
          • 5.2.4.3.6.5. Rest of ASEAN
        • 5.2.4.3.7. Rest of Asia Pacific
      • 5.2.4.4. Middle East & Africa
        • 5.2.4.4.1. UAE
        • 5.2.4.4.2. Saudi Arabia
        • 5.2.4.4.3. South Africa
        • 5.2.4.4.4. Rest of MEA
      • 5.2.4.5. South America
        • 5.2.4.5.1. Argentina
        • 5.2.4.5.2. Brazil
        • 5.2.4.5.3. Rest of South America

Chapter 6. North America Marine Oligosaccharides Market Analysis

  • 6.1. Market Dynamics and Trends
    • 6.1.1. Growth Drivers
    • 6.1.2. Restraints
    • 6.1.3. Opportunity
    • 6.1.4. Key Trends
  • 6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 6.2.1. By Product Type
    • 6.2.2. By Source
    • 6.2.3. By Application
    • 6.2.4. By Country

Chapter 7. Europe Marine Oligosaccharides Market Analysis

  • 7.1. Market Dynamics and Trends
    • 7.1.1. Growth Drivers
    • 7.1.2. Restraints
    • 7.1.3. Opportunity
    • 7.1.4. Key Trends
  • 7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 7.2.1. By Product Type
    • 7.2.2. By Source
    • 7.2.3. By Application
    • 7.2.4. By Country

Chapter 8. Asia Pacific Marine Oligosaccharides Market Analysis

  • 8.1. Market Dynamics and Trends
    • 8.1.1. Growth Drivers
    • 8.1.2. Restraints
    • 8.1.3. Opportunity
    • 8.1.4. Key Trends
  • 8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 8.2.1. By Product Type
    • 8.2.2. By Source
    • 8.2.3. By Application
    • 8.2.4. By Country

Chapter 9. Middle East & Africa Marine Oligosaccharides Market Analysis

  • 9.1. Market Dynamics and Trends
    • 9.1.1. Growth Drivers
    • 9.1.2. Restraints
    • 9.1.3. Opportunity
    • 9.1.4. Key Trends
  • 9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 9.2.1. By Product Type
    • 9.2.2. By Source
    • 9.2.3. By Application
    • 9.2.4. By Country

Chapter 10. South America Marine Oligosaccharides Market Analysis

  • 10.1. Market Dynamics and Trends
    • 10.1.1. Growth Drivers
    • 10.1.2. Restraints
    • 10.1.3. Opportunity
    • 10.1.4. Key Trends
  • 10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 10.2.1. By Product Type
    • 10.2.2. By Source
    • 10.2.3. By Application
    • 10.2.4. By Country

Chapter 11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 11.1. FMC Corporation
  • 11.2. Alfa Chemistry
  • 11.3. Gobalsir Inc
  • 11.4. Cargill
  • 11.5. DSM
  • 11.6. DuPont de Nemours, Inc.
  • 11.7. CP Kelco
  • 11.8. KIMICA Corporation
  • 11.9. Gelymar S.A.
  • 11.10. Qingdao BZ Oligo Biotech Co., Ltd.
  • 11.11. Golden-Shell Pharmaceutical Co., Ltd.
  • 11.12. Seagarden AS
  • 11.13. Algaia S.A.
  • 11.14. BioAtlantis Ltd.
  • 11.15. Other Prominent Players

Chapter 12. Annexure

  • 12.1. List of Secondary Sources
  • 12.2. Macro-Economic Outlook/Indicators